Year |
Citation |
Score |
2023 |
Huang Q, Chen AT, Chan KY, Sorensen H, Barry AJ, Azari B, Zheng Q, Beddow T, Zhao B, Tobey IG, Moncada-Reid C, Eid FE, Walkey CJ, Ljungberg MC, Lagor WR, ... ... Deverman BE, et al. Targeting AAV vectors to the central nervous system by engineering capsid-receptor interactions that enable crossing of the blood-brain barrier. Plos Biology. 21: e3002112. PMID 37467291 DOI: 10.1371/journal.pbio.3002112 |
0.56 |
|
2020 |
Ravindra Kumar S, Miles TF, Chen X, Brown D, Dobreva T, Huang Q, Ding X, Luo Y, Einarsson PH, Greenbaum A, Jang MJ, Deverman BE, Gradinaru V. Multiplexed Cre-dependent selection yields systemic AAVs for targeting distinct brain cell types. Nature Methods. PMID 32313222 DOI: 10.1038/S41592-020-0799-7 |
0.399 |
|
2019 |
Zeng J, Wang Y, Luo Z, Chang LC, Yoo JS, Yan H, Choi Y, Xie X, Deverman BE, Gradinaru V, Gupton SL, Zlokovic BV, Zhao Z, Jung JU. TRIM9-Mediated Resolution of Neuroinflammation Confers Neuroprotection upon Ischemic Stroke in Mice. Cell Reports. 27: 549-560.e6. PMID 30970257 DOI: 10.1016/J.Celrep.2018.12.055 |
0.336 |
|
2019 |
Challis RC, Ravindra Kumar S, Chan KY, Challis C, Beadle K, Jang MJ, Kim HM, Rajendran PS, Tompkins JD, Shivkumar K, Deverman BE, Gradinaru V. Systemic AAV vectors for widespread and targeted gene delivery in rodents. Nature Protocols. PMID 30626963 DOI: 10.1038/S41596-018-0097-3 |
0.349 |
|
2018 |
Deverman BE, Ravina BM, Bankiewicz KS, Paul SM, Sah DWY. Gene therapy for neurological disorders: progress and prospects. Nature Reviews. Drug Discovery. PMID 30093643 DOI: 10.1038/Nrd.2018.110 |
0.337 |
|
2018 |
Bedbrook CN, Deverman BE, Gradinaru V. Viral Strategies for Targeting the Central and Peripheral Nervous Systems. Annual Review of Neuroscience. PMID 29709207 DOI: 10.1146/Annurev-Neuro-080317-062048 |
0.375 |
|
2017 |
Chan KY, Jang MJ, Yoo BB, Greenbaum A, Ravi N, Wu WL, Sánchez-Guardado L, Lois C, Mazmanian SK, Deverman BE, Gradinaru V. Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems. Nature Neuroscience. PMID 28671695 DOI: 10.1038/Nn.4593 |
0.352 |
|
2016 |
Deverman BE, Pravdo PL, Simpson BP, Kumar SR, Chan KY, Banerjee A, Wu WL, Yang B, Huber N, Pasca SP, Gradinaru V. Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain. Nature Biotechnology. PMID 26829320 DOI: 10.1038/Nbt.3440 |
0.366 |
|
2016 |
Farshim PP, Deverman BE, Bates GP. L3 Systemic administration of a novel AAV variant results in widespread and efficient gene transfer in R6/2 mice Journal of Neurology, Neurosurgery & Psychiatry. 87: A91.1-A91. DOI: 10.1136/Jnnp-2016-314597.258 |
0.362 |
|
2016 |
Deverman BE, Pravdo PL, Simpson BP, Kumar SR, Luo Y, Chan KY, Banerjee A, Wu W, Yang B, Huber N, Pasca SP, Gradinaru V. 252. Using Cre-Dependent In Vivo Selection to Identify AAV Variants That Enable Efficient and Widespread Gene Transfer to the Adult Central Nervous System Molecular Therapy. 24: S99. DOI: 10.1016/S1525-0016(16)33061-1 |
0.379 |
|
2013 |
Dho SH, Deverman BE, Lapid C, Manson SR, Gan L, Riehm JJ, Aurora R, Kwon KS, Weintraub SJ. Control of cellular Bcl-xL levels by deamidation-regulated degradation. Plos Biology. 11: e1001588. PMID 23823868 DOI: 10.1371/Journal.Pbio.1001588 |
0.685 |
|
2012 |
Deverman BE, Patterson PH. Exogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelination. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 2100-9. PMID 22323722 DOI: 10.1523/Jneurosci.3803-11.2012 |
0.32 |
|
2009 |
Deverman BE, Patterson PH. Cytokines and CNS development. Neuron. 64: 61-78. PMID 19840550 DOI: 10.1016/J.Neuron.2009.09.002 |
0.306 |
|
2007 |
Weintraub SJ, Deverman BE. Chronoregulation by asparagine deamidation. Science's Stke : Signal Transduction Knowledge Environment. 2007: re7. PMID 17957089 DOI: 10.1126/Stke.4092007Re7 |
0.664 |
|
2004 |
Weintraub SJ, Manson SR, Deverman BE. Resistance to antineoplastic therapy. The oncogenic tyrosine kinase-Bcl-x(L) axis. Cancer Cell. 5: 3-4. PMID 14749119 DOI: 10.1016/S1535-6108(03)00338-6 |
0.644 |
|
2004 |
Deverman BE, Weintraub SJ. 984: The Sodium/Hydrogen Exchanger 1 Protein in the Bladder Cancer Response to Cisplatin Treatment Journal of Urology. 171: 260-261. DOI: 10.1016/S0022-5347(18)38221-1 |
0.625 |
|
2003 |
Deverman BE, Cook BL, Manson SR, Niederhoff RA, Langer EM, Rosová I, Kulans LA, Fu X, Weinberg JS, Heinecke JW, Roth KA, Weintraub SJ. Bcl-xL Deamidation Is a Critical Switch in the Regulation of the Response to DNA Damage Cell. 115: 503. DOI: 10.1016/S0092-8674(03)00892-4 |
0.615 |
|
2002 |
Deverman BE, Cook BL, Manson SR, Niederhoff RA, Langer EM, Rosová I, Kulans LA, Fu X, Weinberg JS, Heinecke JW, Roth KA, Weintraub SJ. Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage. Cell. 111: 51-62. PMID 12372300 DOI: 10.1016/S0092-8674(02)00972-8 |
0.663 |
|
2000 |
He S, Cook BL, Deverman BE, Weihe U, Zhang F, Prachand V, Zheng J, Weintraub SJ. E2F is required to prevent inappropriate S-phase entry of mammalian cells. Molecular and Cellular Biology. 20: 363-71. PMID 10594038 DOI: 10.1128/Mcb.20.1.363-371.2000 |
0.631 |
|
Show low-probability matches. |